Continuos intravenous infusion of atrial natriuretic peptide (ANP) prevented liver fibrosis in rat

Biochemical and Biophysical Research Communications

Volumn 378, Issue 3, 2009, Pages 354-359

  Ishigaki, Noriko ^a   Yamamoto, Naoki ^a   Jin, Haiyan ^a   Uchida, Kouichi ^a   Terai, Shuji ^a   Sakaida, Isao ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial natriuretic peptide; Fibrosis; Hepatic stellate cell(s); Infusion pump

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA SMOOTH MUSCLE ACTIN; ASPARTATE AMINOTRANSFERASE; ATRIAL NATRIURETIC FACTOR; DIMETHYLNITROSAMINE; DIMETHYLNITROSAMINE DEMETHYLASE; GELATINASE A; HYALURONIC ACID; HYDROXYPROLINE; PROCOLLAGEN; PROCOLLAGEN TYPE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL GROWTH; CONTINUOUS INFUSION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; INFUSION PUMP; LIVER CELL; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STELLATE CELL; WISTAR RAT;

ACTINS; ANIMALS; ATRIAL NATRIURETIC FACTOR; CELL LINE; DIMETHYLNITROSAMINE; GENE EXPRESSION; INFUSIONS, INTRAVENOUS; LIVER CIRRHOSIS; MALE; PROCOLLAGEN; RATS; RATS, WISTAR; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 57749175319     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.10.154     Document Type: Article

References (21)

1. Friedman S.L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med. 328 (1993) 1828-1835
2. de Bold A.J., Borenstein H.B., Veress A.T., and Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28 (1981) 89-94
3. Kulhanek-Heinze S., Gerbes A.L., Gerwig T., Vollmar A.M., and Kiemer A.K. Protein kinase A dependent signalling mediates anti-apoptotic effects of the atrial natriuretic peptide in ischemic livers. J. Hepatol. 41 (2004) 414-420
4. Green A.K., Stratton R.C., Squires P.E., and Simpson A.W. Atrial natriuretic peptide attenuates elevations in Ca2+ and protects hepatocytes by stimulating net plasma membrane Ca2+ efflux. J. Biol. Chem. 282 (2007) 34542-34554
5. Bilzer M., Witthaut R., Paumgartner G., and Gerbes A.L. Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology 106 (1994) 143-151
6. Gerbes A.L., Vollmar A.M., Kiemer A.K., and Bilzer M. The guanylate cyclase-coupled natriuretic peptide receptor: a new target for prevention of cold ischemia-reperfusion damage of the rat liver. Hepatology 28 (1998) 1309-1317
7. Gerwig T., Meissner H., Bilzer M., Kiemer A.K., Arnholdt H., Vollmar A.M., and Gerbes A.L. Atrial natriuretic peptide preconditioning protects against hepatic preservation injury by attenuating necrotic and apoptotic cell death. J. Hepatol. 39 (2003) 341-348
8. Jin H., Yamamoto N., Uchida K., Terai S., and Sakaida I. Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient l-amino acid-defined diet. Biochem. Biophys. Res. Commun. 364 (2007) 801-807
9. Jin H., Terai S., and Sakaida I. The iron chelator deferoxamine causes activated hepatic stellate cells to become quiescent and to undergo apoptosis. J. Gastroenterol. 42 (2007) 475-484
10. Sakaida I., Matsumura Y., Kubota M., Kayano K., Takenaka K., and Okita K. The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline-deficient l-amino acid-defined diet. Hepatology 23 (1996) 755-763
11. Wu J., Liu S.L., Zhu J.L., Norton P.A., Nojiri S., Hoek J.B., and Zern M.A. Roles of tissue transglutaminase in ethanol-induced inhibition of hepatocyte proliferation and alpha 1-adrenergic signal transduction. J. Biol. Chem. 275 (2000) 22213-22219
12. Bataller R., Sancho-Bru P., Gines P., Lora J.M., Al-Garawi A., Sole M., Colmenero J., Nicolas J.M., Jimenez W., Weich N., Gutierrez-Ramos J.C., Arroyo V., and Rodes J. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125 (2003) 117-125
13. Bataller R., Gines P., Nicolas J.M., Gorbig M.N., Garcia-Ramallo E., Gasull X., Bosch J., Arroyo V., and Rodes J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology 118 (2000) 1149-1156
14. Paizis G., Cooper M.E., Schembri J.M., Tikellis C., Burrell L.M., and Angus P.W. Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123 (2002) 1667-1676
15. Lo C.S., Chen Z.H., Hsieh T.J., and Shin S.J. Atrial natriuretic peptide attenuates high glucose-activated transforming growth factor-beta, Smad and collagen synthesis in renal proximal tubular cells. J. Cell. Biochem. 103 (2008) 1999-2009
16. Stratton R.C., Squires P.E., and Green A.K. ANP stimulates hepatocyte Ca2+ efflux via plasma membrane recruitment of PKGIalpha. Biochem. Biophys. Res. Commun. 368 (2008) 965-970
17. Carini R., De Cesaris M.G., Splendore R., Domenicotti C., Nitti M.P., Pronzato M.A., and Albano E. Mechanisms of hepatocyte protection against hypoxic injury by atrial natriuretic peptide. Hepatology 37 (2003) 277-285
18. Colucci W.S., Elkayam U., Horton D.P., Abraham W.T., Bourge R.C., Johnson A.D., Wagoner L.E., Givertz M.M., Liang C.S., Neibaur M., Haught W.H., and LeJemtel T.H. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. N. Engl. J. Med. 343 (2000) 246-253
19. Brenard R., Moreau R., Pussard E., Champigneulle B., Gaudin C., Hadengue A., Braillon A., and Lebrec D. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis. J. Hepatol. 14 (1992) 347-356
20. Gorbig M.N., Gines P., Bataller R., Nicolas J.M., Garcia-Ramallo E., Tobias E., Titos E., Rey M.J., Claria J., Arroyo V., and Rodes J. Atrial natriuretic peptide antagonizes endothelin-induced calcium increase and cell contraction in cultured human hepatic stellate cells. Hepatology 30 (1999) 501-509
21. Sansoe G., Aragno M., Mastrocola R., Restivo F., Mengozzi G., Smedile A., Rosina F., Danni O., Parola M., and Rizzetto M. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?. J. Hepatol. 43 (2005) 791-798